ClinicalTrials.gg
CompletedNCT05467488Updated Sep 6, 2023

Light-induced Effects on Dental Implant Stability

An interventional study of photofunctionalization in Missing Teeth, sponsored by Prof. Abdul Mueed Zaigham. Completed at 1 site in Pakistan. Open to participants aged 21 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-06.

Sponsored by Prof. Abdul Mueed Zaigham · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Jun 2017, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
21 Years to 60 Years
Sex
All
01

Study summary

Until now, limited research has observed the stability of photo functionalized sandblasted acid-etched (SLA) titanium implants. The study includes a sample size of sixty otherwise healthy patients with implant replacement, comparing nonirradiated, irradiated UVA and UVC titanium implants. It was an interventional study with a sample size divided into three groups using simple randomization. Patients with nonirradiated dental implants make the control group A with UVA and UVC dental implants forming groups B and C, respectively. Before functional loading, implant stability was measured on days zero and eight weeks. SPSS 26.0 is used for data analysis. The data for implant stability quotient (ISQ) levels and osseointegration speed index (OSI) were presented as mean ± SD for each group. The effect of UVA and UVC on ISQ2 compared with the baseline ISQ was done by applying multiple simple regression analysis models, whereas the distinction between UVA and UVC was made through a t-test. p ≤ 0.05 was kept statistically significant. The implants irradiated with UVA significantly affected ISQ levels compared to other groups.

02

Conditions studied

  • Missing Teeth

Browse trials for

Keywords

  • dental implants
03

In context

Anodontia

90 studies on the registry are indexed under Anodontia; 23 are open to participants now.

This study's enrollment of 66 is above the median of 30 across 66 interventional studies indexed under Anodontia.

Browse Anodontia studies →

Lead sponsor

This is the only study on the registry with Prof. Abdul Mueed Zaigham as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • systemically healthy patients with age > 20 with at least one tooth or more missing

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • No intervention
    Non irradiated implants (group A)
  • Active comparator
    UVA irradiated group (group B)

    Procedure: photofunctionalization

  • Active comparator
    UVC irradiated group (group C)

    Procedure: photofunctionalization

Interventions

  • Procedurephotofunctionalization

    UVA and UVC photofunctionalization of dental implants

06

What researchers measure

Primary outcomes

  1. ISQ measurement through Ostelltm Mentor device

    The Ostelltm device was initially calibrated using a test peg called the ISQ. A smart peg was used for assessment. The smart peg tightened with 5 Ncm torque is then mounted on implant fixture and the transducer connected perpendicular to the implant . The measuring probe is brought closer to the smart peg without touching it. A beeping sound displays the reading on the monitor. Two successive readings are taken mesiodistally along the jaw and buccolingually perpendicular to the jaw .The RFA measurements taken twice during implant treatment are recorded. All the ISQ values were recorded from one to hundred and a mean was taken.

    Time frame: eight months

07

Study locations

1 site
  • Institute of Dentistry; CMH Lahore Medical College
    Lahore, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2017 to primary completion in Mar 2018, 9 months.

Of 41 non-industry interventional studies with no phase under Anodontia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 9 months is below that.

Counting every sponsor, half of 42 studies reached it within 18 months; a quarter within 11 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2022
First posted
Jul 20, 2022
StartActual
Jun 15, 2017
Primary completionActual
Mar 15, 2018
CompletionActual
Jun 15, 2018
Last update
Sep 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05467488
Lead sponsor
Prof. Abdul Mueed Zaigham
Responsible party
Prof. Abdul Mueed Zaigham (Professor, CMH Lahore Medical College and Institute of Dentistry) — Sponsor-investigator
First posted
Jul 20, 2022
Start date
Jun 15, 2017
Primary completion
Mar 15, 2018
Completion
Jun 15, 2018
Last update
Sep 6, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion